The BNT162b2 mRNA COVID-19 vaccine showed high efficacy in clinical trials but observational data from populations not included in trials are needed. We describe immunogenicity 21 days post-dose 1 among 514 Israeli healthcare workers by age, ethnicity, sex and prior COVID-19 infection. Immunogenicity was similar by ethnicity and sex but decreased with age. Those with prior infection had antibody titres one magnitude order higher than naïve individuals regardless of the presence of detectable IgG antibodies pre-vaccination.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879501 | PMC |
| http://dx.doi.org/10.2807/1560-7917.ES.2021.26.6.2100096 | DOI Listing |
Publication Analysis
Top Keywords
ethnicity sex
12
age ethnicity
8
sex prior
8
prior infection
8
bnt162b2 mrna
8
mrna covid-19
8
covid-19 vaccine
8
healthcare workers
8
impact age
4
infection status
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!